FedEx Named Top Logistics Provider At Asia-Pacific Biopharma Excellence Awards 2024

FedEx Express (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and a leading global express transportation company, has achieved significant recognition at the Asia-Pacific Biopharma Excellence Awards 2024 (ABEA 2024). The company was honored with the title of "Overall Logistics & Supply Chain Management Supplier of the Year" and also secured the "Best Logistics & Supply Chain Management Supplier Award: Last Mile Implementation." These accolades were presented in recognition of FedEx's outstanding contributions to bioprocessing, logistics, supply chain management, and clinical trials within the Asia region.

The awards ceremony, organized by IMAPAC, took place on March 20, 2024, in Singapore. It was part of a series of events that included the 11th Biologics Manufacturing Asia, the 8th BioLogistics World Asia, and the 2nd Clinical Trials Festival Asia. These events collectively brought together hundreds of leaders from the biopharma industry to celebrate excellence and innovation.

FedEx has long been dedicated to enhancing its healthcare logistics capabilities. The company boasts a global network comprising over 680 aircraft and 200,000 vehicles. Additionally, it operates four Life Science Centers located in South Korea, Japan, Singapore, and India. This extensive network is complemented by FedEx's cold chain solutions and real-time monitoring service, FedEx SenseAware, which ensures the integrity of sensitive healthcare shipments.

One of FedEx's specialized services, FedEx Clinical Care, offers an end-to-end shipping solution tailored for the safe and compliant transport of biological samples required for clinical trials. This service is designed to meet the precise speed and temperature conditions necessary for such critical shipments.

Salil Chari, senior vice president of Marketing and Customer Experience for FedEx Express in the Asia Pacific, Middle East, and Africa Region, expressed his gratitude for the recognition. He stated, "The healthcare industry has very specific and carefully regulated logistics needs. Being recognized by voters among the biopharma community is the highest possible recognition we can receive." Chari further emphasized FedEx's commitment to transforming supply chains to be smarter and more efficient through innovative solutions that meet the comprehensive shipping needs of healthcare customers.

The ABEA 2024 awards underscore FedEx's role in advancing healthcare logistics through its sophisticated network and innovative solutions designed to ensure that critical healthcare shipments are delivered safely and efficiently across the globe.

For more insights into healthcare logistics and FedEx's contributions to this vital sector, interested parties are encouraged to explore FedEx Business Insights.